Thromboembolic Disease in Cancer Patients

Thromboembolic disease whose manifestations include pulmonary embolism and deep vein thrombosis, is a serious disease entity that appears at elevated levels among cancer patients compared to the general population. Approximately 20% of all new episodes of venous thrombosis are associated with underlying cancer, while about 26% of cancers have idiopathic thromboembolic disease. Unfortunately, the diagnosis is often made after the onset of pulmonary embolism, with a difficult and not always positive progression. It is important to develop and implement risk assessment protocols, for the possible occurrence, as well as procedures for electronic recording. The challenge for health care professionals in the coming years will be to focus on patient assessment and education in the prevention and early diagnosis of thromboembolic disease.